Australia's hemp pet pioneer since 2018  •  Veterinary CE Course
HempPet Vet HempPetVet
Professional Portal 1300 004 367
Veterinary Continuing Education

The Endocannabinoid System in Companion Animals

A structured clinical course for registered veterinarians — covering receptor anatomy, endogenous ligands, phytocannabinoid pharmacology, clinical applications, and Australian regulatory compliance.

Course Modules

Five evidence-informed modules with interactive checkpoints

1

Module 1: ECS Receptor Anatomy

CB1 and CB2 receptor distribution across canine and feline CNS and peripheral tissues. Comparative localisation and neuropharmacological sensitivity.

Slides
● Available

Checkpoint 1: ECS Anatomy Quiz

Test your understanding of CB1/CB2 receptor distribution and functional roles in companion animals.

Quiz — 2 questions
● Available

Interactive: Endocannabinoid Synthesis Pathway

Explore AEA & 2-AG biosynthesis, receptor binding, and enzymatic clearance by FAAH/MAGL with an interactive diagram.

Interactive Module
● Available — Interactive
2

Module 2: Endogenous Ligands & Metabolism

Anandamide (AEA) and 2-arachidonoylglycerol (2-AG): biosynthesis, signalling, and degradation by FAAH and MAGL.

Slides
● Available

Checkpoint 2: Endogenous Ligands Quiz

Test your understanding of AEA vs 2-AG efficacy, receptor profiles, and enzymatic degradation pathways.

Quiz — 2 questions
● Available

Interactive: Phytocannabinoid Receptor Map

Explore how THC, CBD, CBG & terpenes interact with CB1, CB2, TRPV1, GPR55 & 5-HT1A receptors.

Interactive Module
● Available — Interactive
3

Module 3: Phytocannabinoid Pharmacology

Δ9-THC, CBD, CBG and the terpene entourage effect. Receptor binding profiles, pharmacokinetics, and species-relevant dose considerations.

Slides
● Available

Checkpoint 3: Pharmacology Quiz

Test your understanding of CBD vs THC mechanisms and terpene entourage pharmacology.

Quiz — 2 questions
● Available

Interactive: CBD Clinical Pharmacology Map

Explore CBD hepatic metabolism, clinical applications, THC toxicosis pathway & the >10mg/mL safety threshold.

Interactive Module
● Available — Interactive
4

Module 4: CBD Clinical Applications

Evidence-based CBD in canine epilepsy and osteoarthritis. Peer-reviewed efficacy, pharmacokinetics, and regulatory guidelines.

Slides
● Available
4

Module 4: Cannabis Toxicosis & Safety

Cannabis toxicosis in dogs — clinical manifestations, the >10 mg/mL compounded-preparation safety threshold, and emergency management protocols.

Slides
● Available

Checkpoint 4: Clinical & Toxicology Quiz

Test your understanding of CBD hepatic interactions, THC toxicosis management, and CYP450 drug-drug interactions.

Quiz — 3 questions
● Available

Interactive: Australian Regulatory Framework

Explore SUSMP scheduling, compounding rules, 7-year record-keeping & controlled drug register requirements.

Interactive Module
● Available — Interactive
5

Module 5: Regulatory Compliance & Prescribing

SUSMP scheduling, compounded preparation limits, 7-year record-keeping obligations, and responsible veterinary access pathways.

Slides
● Available

Checkpoint 5: Regulatory Compliance Quiz

Test your understanding of SUSMP scheduling, compounding regulations, and controlled substance record-keeping.

Quiz — 2 questions
● Available

Interactive: Receptor Distribution Mapping

Explore CB1 & CB2 distribution patterns across canine and feline anatomy with an interactive mapping tool.

Interactive Module
● Available — Interactive

Begin the Course

Start with Module 1 — or jump to any module above

Start Module 1 →

Clinical Disclaimer

This course is intended for veterinary continuing education purposes. It does not constitute veterinary advice or a recommendation to prescribe any specific product. Cannabinoid products remain subject to Australian scheduling and regulatory controls. Practitioners should exercise clinical judgement and comply with all applicable state and federal requirements. No therapeutic claims are made for unapproved products.